SciELO - Scientific Electronic Library Online

vol.18 número1Mortalidad hospitalaria en un hospital pediátrico de referencia nacional:: Centro Hospitalario Pereira RossellCaracterización molecular del virus de la hepatitis C en Montevideo-Uruguay índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados



Links relacionados


Revista Médica del Uruguay

versión On-line ISSN 1688-0390


HORTAL, María  y  GRUPO OPS/SIREVA. Uruguay et al. Vigilancia de las neumococcias del niño hospitalizado:: su prevención específica (1994-2000). Rev. Méd. Urug. [online]. 2002, vol.18, n.1, pp.66-75. ISSN 1688-0390.

Summary The aim of this paper are to promote available national information and to analyze the effects of the recently released vaccinations such as serum streptococcus pneumo-niae capsules in infants up to 14 years old. During seven years (1994-2000) 520 isolate invaders were collected in patients with pneumonia (67%), meningitis (21%), bacteremia/sepsis (8%), and other processes (4%) such as peritonitis, osteomyelitis, cellulite, and abscess. Serotype distribution showed a global potentially coverage of 44% with heptavalent vaccine (serotypes 4, 6B, 9V, 14, 18C, 19F and 23F), 77% with nonavalent vaccine (plus serotypes 1 and 5), and 86,9% with 11-valent vaccine (plus serotypes 3 and 7F). Antigenic combination with other serotypes not included in vaccines allows to estimate rate increase up to 53.2%, 86.5% and 95,7% respectively. In patients from 4 months to 5 years old, primary beneficiaries of recent vaccines, coverage rates ranged from 40% (2-5 years) to 67% (4-11 months), whereas nonavalent vaccine showed a better coverage, 78% to 86%. Coverage reached in patients with meningitis was lower compared to patients with pneumonia since serotype dispersion was higher. Forty-three fatal cases (meningitis, 30 and pneumonia, 13) could have potentially been prevented in 67-70%, 73-78% and 93-100% with these new vaccines. Strains with diminished susceptibility to penicillin, countrywide found, were more frequently isolated in cases of pneumonia (39%) than in cases of meningitis (12%). Overall coverage of any of these vaccines was 92% for intermediate resistant strains and 100% for high resistant strains. In summary, considering cost effectiveness, nonava-lent vaccine appears to be as the best choice to prevent invasive pneumococcia, particularly in Uruguayan infants since it includes three of the most frequent serotypes found in this population at risk. Obviously, 11-valent vaccine may widen coverage in case costs were lower.


        · resumen en Español | Francés     · texto en Español     · Español ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons